FFA
AQST icon

Farther Finance Advisors’s Aquestive Therapeutics AQST Stock Holding History

Farther Finance Advisors’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4 Hold
1
– – ﹤0.01% 5948
2026
Q1 		$4 Buy
+1
New +$4 ﹤0.01% 5713

Other funds holding AQST

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
SMAM
Sugar Maple Asset Management Sister Bay, Wisconsin $155M AUM 17.72% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
SWRP
Summit Wealth & Retirement Planning San Ramon, California $472M AUM 25.49% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Farther Finance Advisors's AQST Position: Q2 2026 in Review

Farther Finance Advisors held its Aquestive Therapeutics (AQST) position steady in Q2 2026 at 1 share worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #5948.

Farther Finance Advisors first reported a position in AQST in Q1 2026 and has held it in 2 quarters since. 29 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Farther Finance Advisors held 1 share of Aquestive Therapeutics worth $4 as of Q2 2026.
  • Farther Finance Advisors left its Aquestive Therapeutics share count unchanged in Q2 2026.
  • Aquestive Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5948 holding.
  • Farther Finance Advisors first reported a position in Aquestive Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 29 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.